AzTrials
AzTrials

Cardiopulmonary ArrestROUTINE-FNCT03807206

Resuscitation Outcomes in the Netherlands Flashmob Questionnaire

An observational study of Cardiopulmonary Arrest and DNR-orders, run by Erasmus Medical Center at 12 sites in Netherlands.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study is to gain insight in patients' experiences regarding do not resuscitate conversations and decisions. A multicentre flash mob investigation will be conducted in which data will be obtained over the course of two weeks using electronic questionnaires that patients will fill out. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Cardiopulmonary Arrest, DNR-orders
What is being tested?
Questionnaire
How many people
1,136 participants
Where
12 sitesNetherlands
Study dates
1 Jan 2019to 7 Feb 2019
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: The base population consists of all adult patients admitted to all the participating hospitals. These consist of one academic centre and 10 general hospitals. The sampling is based on non-probability as it does not represent the entire population (i.e. inhabitants of the Netherlands), however it is based on probability sampling when the population is solely patients admitted to hospital.

Who may be able to join

  • All patients admitted to the participating hospitals with a planned admission >24 hours at the moment this study takes place.

Who cannot join

  • • Refusal to participate
  • <18 years of age
  • Admitted in outpatient clinic and day treatment centres (e.g. haemodialysis)
  • Admitted <24 hours, as defined by not sleeping overnight in hospital
  • No reliable proxy in the following situations:
  • Unable to answer questions (e.g. unconscious, cognitively impaired, delirious)
Show all 16Show fewer
  • Language barrier (with no interpreter or family member)
  • The following hospital departments are excluded:
  • Intensive care unit
  • Coronary/acute cardiac care unit
  • Obstetrics
  • Paediatrics
  • Stroke unit
  • Dialysis (outpatient dialysis)
  • Day-care wards/short-stay (i.e. <1 day)
  • Palliative care

Trial locations and contacts

12 sites in 1 country.

12 sites in 1 country

Netherlands12 sites
  • Jeroen Bosch ziekenhuis

    's-Hertogenbosch

  • Rijnstate

    Arnhem

  • Amphia

    Breda

  • Reinier de Graaf gasthuis

    Delft

  • Albert Schweitzer ziekenhuis

    Dordrecht

  • Medisch Spectrum Twente

    Enschede

  • Tergooi ziekenhuizen

    Hilversum

  • Erasmus MC

    Rotterdam, 3015CE

  • Franciscus Gasthuis & Vlietland

    Rotterdam

  • Ikazia

    Rotterdam

  • Maasstad

    Rotterdam

  • Haaglanden Medisch Centrum

    The Hague

Other trials in Netherlands

About this study

Official title: Resucitation Outcomes in the Netherlands: Flash Mob Research on the Subject of Patient Experiences Regarding Do Not Resuscitate Orders.

The aim of this study is to gain insight in patients' experiences regarding do not resuscitate conversations and decisions. A multicentre flash mob investigation will be conducted in which data will be obtained over the course of two weeks using electronic questionnaires that patients will fill out. General demographic data and a brief quality of life assessment (EQ-5D) will be collected. Whether a DNR converstation has taken place will be noted, along with patients' experiences with this conversation. Lastly the patient will be asked about his/her expectations of survival after cardiopulmonary resuscitation.

Read the detailed description

Rationale: In-hospital cardiac arrest, associated with a survival to discharge of 15.0%, results in a good neurologic discharge in 9.1% - 30.0% of patients. Therefore it is recommended to engage in advanced care planning with patients, to discuss do-not-resuscitate (DNR) directives. In current knowledge, there are no published data about the prevalence of these DNR orders and associated factors in hospitalized patients in the Netherlands. Also, the conversation about DNR are sometimes perceived as awkward or untimely by patients.

Objective: The primary goal is to estimate prevalence DNR order in Dutch hospitals. A secondary goal is to assess what geographical, patient and disease factors are associated with DNR status. Furthermore patient experience in the conversation leading to DNR-orders is of interest.

Study design: A cross-sectional point prevalence study, in 10 participating hospitals of the ROUTiNE project.

Study population: Patients who plan to be admitted for more than 24 hours to the participating hospitals, aged 18 or older, who are responsive and conscious.

Main study parameters/endpoints: The prevalence of DNR orders, expressed as number per 1000 beds.

Nature and extent of the burden and risks associated with participation, benefit and group relatedness: There is no risk. Only one ten-minute interview per participant. Therefore the benefit of this study (as described in the objectives) outweigh the potential risks.

Being tested
Questionnaire
Medical subject headings
Heart Arrest

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • QuestionnaireBehavioural

    Also called structured interview

    Patient questionnaire

Study groups in NCT03807206
Study groupRoleWhat they receive
Flashmob 2019Patients from the following hospitals will receive a questionnaire/structured intereview: Erasmus MC, Franciscus Gasthuis \& Vlietland, Ikazia, Haaglanden Medisch Centrum, Albert Schweitzer ziekenhuis, Jeroen Bosch ziekenhuis, Rijnstate ziekenhuis, Amphia ziekenhuis, Tergooi klinieken, Medisch Spectrum Twente, Reinier de Graaf gasthuis. Pending: Maasstad ziekenhuis
Receives: Behavioral: Questionnaire

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Prevalence of DNR-orders

    Percentage of DNR-orders in the total cohort as noted in the electronic patient file

    Measured: 1 day

Secondary outcomes (4)
  1. DNR-order discussion prevalence

    Number of patients who have had a DNR discussion with their physician

    Measured: 1 day

  2. DNR-order discussion experience

    Patient experience with the DNR-order discussion; was it timely, was the explanation clear?

    Measured: 1 day

  3. DNR-order discrepancy

    DNR-order reported by the patient, compared to DNR-order from the electronic patient file

    Measured: 1 day

  4. Quality of life

    EQ-5D (Euroqol): EQ-5D-5L is a standardized, participant-rated instrument for use as a measure of health outcomes. The EQ 5D-5L includes 2 components: the EQ-5D-5L descriptive system and the visual analogue scale (VAS). The EQ-5D-5L descriptive system provides a profile of the participant's health state in 5 dimensions (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression). For each dimension, the participant is instructed to choose one of 5 levels that best describes their health on that day: "no problem" (1), "slight" (2), "moderate" (3), "severe" (4), or "unable/extreme" (5). The VAS is the participant's rating of their health on a scale of 0 "worst health you can imagine" to 100 "best health you can imagine".

    Measured: 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Jan 2019
  2. Study start1 Jan 2019
  3. Primary completion7 Feb 2019
  4. Study completion7 Feb 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
1,136 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03807206
Sponsor's protocol ID
ROUTINE-F
Acronym
ROUTINE-F
Status last verified
Jul 2019
First submitted
7 Jan 2019
Last updated
16 Jul 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Because of the personal nature of data (reg. age, sex, religion, eductional level) we will not make it available.

Questions about this trial

What is this clinical trial studying?

An observational study of Cardiopulmonary Arrest and DNR-orders, run by Erasmus Medical Center at 12 sites in Netherlands.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 16 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Jul 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 12 sites in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Prevalence of DNR-orders (time frame: 1 day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jul 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in